Alendronate Sodium Tablets
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D2-25-R-0023
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency (DLA) Troop Support Medical is soliciting proposals for Alendronate Sodium Tablets under solicitation number SPE2D2-25-R-0023. This procurement seeks to establish a national contract for two line items: Alendronate Sodium 35mg tablets with an estimated annual quantity of 52,228 boxes and 70mg tablets with an estimated annual quantity of 393,517 boxes. Offerors must comply with FDA current Good Manufacturing Practices, provide detailed manufacturing information, and submit comprehensive documentation including representations, certifications, past performance history, and subcontracting plans for large businesses. The solicitation will be evaluated using a lowest price technically acceptable (LPTA) methodology, where offers will be assessed on technical acceptability and pricing. The electronic proposal deadline is November 3, 2025, at 3:00 PM ET via the Defense Logistics Agency Internet Bid Board System (DIBBS), with this date representing an extension from the original September 25, 2025 deadline.
This solicitation includes no set-aside designations and will serve the Department of Defense, Indian Health Service, and other federal agencies through Pharmaceutical Prime Vendor (PPV) contractors. The contract structure includes a base year and four option years for a maximum contract duration of five years. The specific award value or budget range has not been disclosed in the solicitation materials. Performance requirements include quarterly sales reporting, compliance with product registration and labeling specifications, and provisions for cost recovery fees and backorder situations. While no current incumbent contractor is identified in the available documentation, vendors should note that the contract will be administered by the DLA Troop Support Medical Supply Chain, based in Philadelphia, Pennsylvania, with products ultimately distributed to federal healthcare facilities and systems nationwide.
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 has been issued to extend the solicitation closing date to November 3, 2025.
All other terms and conditions of the solicitation remain unchanged.
Update #1 ·
Solicitation for SPE2D2-25-R-0023 is attached.
Files
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D225R00230001.PDF | ||
| Alendronate Sodium Solicitation - SPE2D2-25-R-0023.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Alendronate Sodium Tablets | Award Notice | |
| This notice | Solicitation | |
| Alendronate Sodium Tablets | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity